ADMA Biologics Inc Stock News

Gilead Announces Approval of Veklury® (remdesivir) in Japan for Patients With Severe COVID-19 | STL.News | Read business news at STL.News.

San Francisco's residents recall what it was like to live in the city that was once the center of the HIV epidemic. The memories stayed with them, and are informing their response to Covid-19.

The companies, however, returned 2/3 of the loans they received under the paycheck protection program.

A summary of the biggest developments in the global coronavirus outbreak

Fauci and heads of CDC and FDA potentially exposed to coronavirus; Boris Johnson to announce UK lockdown changes

A research group that recommends drug pricing has pegged remdesivir’s price at $4,500 or $10 for a course of treatment. The source of that disparity: Whethe you’re looking at production costs or c

"I have felt not to get bullish on a vaccine until Fauci said, 'Get bullish,'" said CNBC's Jim Cramer, suggesting the White House advisor's positive comments may be that bullish call.

Wall Street securities analysts on Thursday revised their ratings and price targets on several U.S.-listed companies, including Ashland Global Holdings, Lyft and Solaredge Technologies. HIGH

At this time, I would like to introduce Mr. Sam Martin, Managing Director at Argot Partners, ADMA's Investor Relations firm. Welcome everyone, and thank you for joining us this afternoon to discuss A

Pompeo left the door open for more trade talks between the U.S. and China even as he tripled down on accusations that the country's leadership sought to conceal information about the origins of the sp

The CoVIg-19 Plasma Alliance, an unprecedented plasma industry collaboration recently established to accelerate the development of a plasma-derived hyperimmune globulin therapy for COVID-19, is rapidl

RAMSEY, N.J. and BOCA RATON, Fla., May 07, 2020 -- ADMA Biologics, Inc. (NASDAQ: ADMA) (“ADMA”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing,.